CAS 915019-65-7 appears in our catalog under these names: Dactolisib (NVP-BEZ 235), NVP-BEZ 235, Dactolisib/ 99.71% (existing batch purity), BEZ235 (NVP–BEZ235), NVP-BEZ235. Offered by: Chemat Brand, TRC, TargetMol, GLPBio, Chemat. Available pack sizes: on request, 10mg, 25mg, 50mg, 100mg, 200mg, 500mg, 5mg.
Dactolisib is an imidazoquinoline that is 3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]quinoline substituted at position 1 by a 4-(1-cyanoisopropyl)phenyl group and at position 8 by a quinolin-3-yl group. A dual PI3K/mTOR inhibitor used in cancer treatment. It has a role as an antineoplastic agent, an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor and a mTOR inhibitor. It is a nitrile, a member of quinolines, a ring assembly, an imidazoquinoline and a member of ureas.
Source: ChEBI
| Molecular formula | C30H23N5O |
|---|---|
| Molecular weight | 469.5 g/mol |
| IUPAC name | 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c]quinolin-1-yl)phenyl]propanenitrile |
| InChIKey | JOGKUKXHTYWRGZ-UHFFFAOYSA-N |
| SMILES | CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5 |
Computed by PubChem (NCBI)